BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24343546)

  • 1. Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands.
    Kroep S; Lansdorp-Vogelaar I; Rubenstein JH; Lemmens VE; van Heijningen EB; Aragonés N; van Ballegooijen M; Inadomi JM
    Am J Gastroenterol; 2014 Mar; 109(3):336-43; quiz 335, 344. PubMed ID: 24343546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.
    Kong CY; Nattinger KJ; Hayeck TJ; Omer ZB; Wang YC; Spechler SJ; McMahon PM; Gazelle GS; Hur C
    Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2450-6. PubMed ID: 21930957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in esophageal adenocarcinoma incidence and mortality.
    Hur C; Miller M; Kong CY; Dowling EC; Nattinger KJ; Dunn M; Feuer EJ
    Cancer; 2013 Mar; 119(6):1149-58. PubMed ID: 23303625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007.
    Abrams JA; Sharaiha RZ; Gonsalves L; Lightdale CJ; Neugut AI
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):183-6. PubMed ID: 21127287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
    Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
    J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends.
    Thrift AP; Whiteman DC
    Ann Oncol; 2012 Dec; 23(12):3155-3162. PubMed ID: 22847812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide Inverse Association between Gastric Cancer and Esophageal Adenocarcinoma Suggesting a Common Environmental Factor Exerting Opposing Effects.
    Derakhshan MH; Arnold M; Brewster DH; Going JJ; Mitchell DR; Forman D; McColl KE
    Am J Gastroenterol; 2016 Feb; 111(2):228-39. PubMed ID: 26753891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.
    Dixon JL; Copeland LA; Zeber JE; MacCarthy AA; Reznik SI; Smythe WR; Rascoe PA
    Dis Esophagus; 2016 Oct; 29(7):747-751. PubMed ID: 26455587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014.
    Islami F; DeSantis CE; Jemal A
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):429-439. PubMed ID: 29902641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.
    Arnold M; Laversanne M; Brown LM; Devesa SS; Bray F
    Am J Gastroenterol; 2017 Aug; 112(8):1247-1255. PubMed ID: 28585555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is young-onset esophageal adenocarcinoma increasing in Japan? An analysis of population-based cancer registries.
    Saito E; Yano T; Hori M; Yoneoka D; Matsuda T; Chen Y; Katanoda K
    Cancer Med; 2022 Mar; 11(5):1347-1356. PubMed ID: 35077026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemic of esophageal adenocarcinoma.
    el-Serag HB
    Gastroenterol Clin North Am; 2002 Jun; 31(2):421-40, viii. PubMed ID: 12134611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study.
    Verbeek RE; van Oijen MG; ten Kate FJ; Vleggaar FP; Schipper ME; Casparie MK; van Baal JW; Siersema PD
    Am J Gastroenterol; 2012 Apr; 107(4):534-42. PubMed ID: 22270082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Barrett's esophagus and esophageal adenocarcinoma in Spain. A unicentric study.
    Arroyo-Martínez Q; Rodríguez-Téllez M; García-Escudero A; Brugal-Medina J; González-Cámpora R; Caunedo Álvarez Á
    Rev Esp Enferm Dig; 2016 Oct; 108(10):609-617. PubMed ID: 27616661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling.
    Kong CY; Kroep S; Curtius K; Hazelton WD; Jeon J; Meza R; Heberle CR; Miller MC; Choi SE; Lansdorp-Vogelaar I; van Ballegooijen M; Feuer EJ; Inadomi JM; Hur C; Luebeck EG
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):997-1006. PubMed ID: 24692500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International trends in esophageal cancer incidence rates by histological subtype (1990-2012) and prediction of the rates to 2030.
    Lin Y; Wang HL; Fang K; Zheng Y; Wu J
    Esophagus; 2022 Oct; 19(4):560-568. PubMed ID: 35689719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.
    Desai M; Lieberman DA; Kennedy KF; Hamade N; Thota P; Parasa S; Gorrepati VS; Bansal A; Gupta N; Gaddam S; Young PE; Mathur S; Moawad FJ; Cash BD; Sampliner R; Vargo JJ; Falk GW; Sharma P
    Gastrointest Endosc; 2019 Feb; 89(2):257-263.e3. PubMed ID: 30342028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Runge TM; Abrams JA; Shaheen NJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epidemiology of Esophageal Adenocarcinoma.
    Coleman HG; Xie SH; Lagergren J
    Gastroenterology; 2018 Jan; 154(2):390-405. PubMed ID: 28780073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.